Live feed
Filing
SC 13D/A
SC 13D/A0001072613-22-000647·New Enterprise Associates 14, L.P.
Schedule 13D ownership disclosure
OYSTER POINT PHARMA INC
Security class unavailable · CUSIP: 69242L106
Event date: 2022-11-07
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 22.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001072613-22-000647
- Form type
- SC 13D/A
- Filer
- New Enterprise Associates 14, L.P.
- CIK
- CIK 1544328
- Filed
- Nov 21, 2022
- Reporting period
- Nov 07, 2022
- Description
- Schedule 13D beneficial ownership